Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria

Jakub Ząbek; Agnieszka Palacz; Iwona Krzewska; Joanna Pyka; Sławomir Maśliński

Abstract

6/2006 vol. 44

Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria

Jakub Ząbek

,

Agnieszka Palacz

,

Iwona Krzewska

,

Joanna Pyka

,

Sławomir Maśliński

Reumatologia 2006; 44, 6: 293–297

Online publish date: 2006/12/15

View full text

AMA

Ząbek J, Palacz A, Krzewska I, Pyka J, Maśliński S. Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria. Reumatologia/Rheumatology. 2006;44(6):293-297.

APA

Ząbek, J., Palacz, A., Krzewska, I., Pyka, J., & Maśliński, S. (2006). Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria. Reumatologia/Rheumatology, 44(6), 293-297.

Chicago

Ząbek, Jakub, Agnieszka Palacz, Iwona Krzewska, Joanna Pyka, and Sławomir Maśliński. 2006. "Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria". Reumatologia/Rheumatology 44 (6): 293-297.

Harvard

Ząbek, J., Palacz, A., Krzewska, I., Pyka, J., and Maśliński, S. (2006). Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria. Reumatologia/Rheumatology, 44(6), pp.293-297.

MLA

Ząbek, Jakub et al. "Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria." Reumatologia/Rheumatology, vol. 44, no. 6, 2006, pp. 293-297.

Vancouver

Ząbek J, Palacz A, Krzewska I, Pyka J, Maśliński S. Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria. Reumatologia/Rheumatology. 2006;44(6):293-297.

Authors are presenting preliminary data introducing a new way of complex analysis of the sera (ANA-positive but without estimated certain specificity), using for the neutralization and removing of “masking” (competing) antibodies (in the test ANA-Hep-2) a full bovine and spleen soluble protein extracts/called ENA, followed by further analysis of the antibody specificities present in neutralized sera by specific ELISA or Western-blott tests dependently on the basic pattern of ANA in the serum.